Is withdrawing treatment really more problematic than withholding treatment?

allocation of healthcare resources clinical ethics criminal law decision-making distributive justice

Journal

Journal of medical ethics
ISSN: 1473-4257
Titre abrégé: J Med Ethics
Pays: England
ID NLM: 7513619

Informations de publication

Date de publication:
11 2021
Historique:
received: 21 04 2020
revised: 30 04 2020
accepted: 04 05 2020
pubmed: 27 5 2020
medline: 3 11 2021
entrez: 27 5 2020
Statut: ppublish

Résumé

There is a concern that as a result of COVID-19 there will be a shortage of ventilators for patients requiring respiratory support. This concern has resulted in significant debate about whether it is appropriate to withdraw ventilation from one patient in order to provide it to another patient who may benefit more. The current advice available to doctors appears to be inconsistent, with some suggesting withdrawal of treatment is more serious than withholding, while others suggest that this distinction should not be made. We argue that there is no ethically relevant difference between withdrawing and withholding treatment and that suggesting otherwise may have problematic consequences. If doctors are discouraged from withdrawing treatment, concern about a future shortage may make them reluctant to provide ventilation to patients who are unlikely to have a successful outcome. This may result in underutilisation of available resources. A national policy is urgently required to provide doctors with guidance about how patients should be prioritised to ensure the maximum benefit is derived from limited resources.

Identifiants

pubmed: 32451343
pii: medethics-2020-106330
doi: 10.1136/medethics-2020-106330
pmc: PMC7295851
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

722-726

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 104848
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 104848/Z/14/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203132
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: DW was a co-author of the British Medical Association COVID-19: ethical issues document and is a member of the British Medical Association Medical Ethics Committee.

Auteurs

James Cameron (J)

Melbourne Law School, The University of Melbourne, Carlton, Victoria, Australia jamesamcameron@gmail.com.
Murdoch Childrens Research Institute, Parkville, Victoria, Australia.

Julian Savulescu (J)

Melbourne Law School, The University of Melbourne, Carlton, Victoria, Australia.
Murdoch Childrens Research Institute, Parkville, Victoria, Australia.
Oxford Uehiro Centre for Practical Ethics, University of Oxford, Oxford, UK.

Dominic Wilkinson (D)

Murdoch Childrens Research Institute, Parkville, Victoria, Australia.
Oxford Uehiro Centre for Practical Ethics, University of Oxford, Oxford, UK.
Newborn Care, John Radcliffe Hospital, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH